Skip to main content

Table 1 Patient baseline characteristics

From: Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis

  

Cohort 1

 ≥ 2 on treatment, ≥ 2 post-treatment assessments

Cohort 2

 ≥ 1 on treatment, ≥ 1 post-treatment assessments

Characteristic

Statistic or Category

eGFR Analysis

(n = 20)

TKV Analysis

(n = 11)

eGFR Analysis

(n = 82)

TKV Analysis

(n = 88)

Age, years

Mean (SD)

39.9 (8.5)

40.9 (8.1)

40.3 (7.4)

40.7 (7.2)

Median

41.2

41.3

41.1

41.5

Min, Max

23.6, 50.2

23.6, 50.2

23.6, 52.1

23.6, 51.9

Sex

Male

6 (30%)

3 (27%)

40 (49%)

43 (49%)

Female

14 (70%)

8 (73%)

42 (51%)

45 (51%)

Race

White

19 (95%)

11 (100%)

76 (93%)

80 (91%)

Black

1 (5%)

0

3 (4%)

4 (5%)

Hispanic

0

0

3 (4%)

4 (5%)

Other

0

0

0

0

Height, m

Mean (SD)

1.72 (0.11)

1.72 (0.11)

1.73 (0.11)

1.74 (0.11)

Weight, kg

Mean (SD)

77.1 (16.6)

77.7 (18.3)

78.3 (16.9)

79.5 (17.3)

Body mass index, kg/m2

Mean (SD)

25.8 (3.5)

25.9 (3.3)

26.0 (4.3)

26.2 (4.6)

Age at ADPKD diagnosis, years

Mean (SD)

27.7 (9.6)

25.5 (8.2)

27.3 (9.3)

27.6 (9.1)

Chronic kidney disease stage, mL/min/1.73 m2

 ≥ 90 (stage G1)

10 (50%)

5 (50%)

29 (35%)

22 (25%)

60 to < 90 (stage G2)

5 (25%)

1 (10%)

32 (39%)

37 (43%)

30 to < 60 (stage G3)

5 (25%)

4 (40%)

21 (26%)

28 (32%)

 < 30 (stage G4)

0

0

0

0

Baseline eGFR, mL/min/1.73 m2

Mean (SD)

84 (26)

82 (27)

80 (22)

75 (22)

Min, Max

44, 122

45, 116

36, 126

34, 126

Systolic blood pressure, mmHg

Mean (SD)

127.0 (13.1)

125.0 (11.6)

125.4 (11.6)

124.7 (11.7)

Diastolic blood pressure, mmHg

Mean (SD)

80.3 (9.6)

81.2 (11.2)

79.6 (7.9)

79.8 (8.7)

TKV, mL

Mean (SD)

2109 (1467)

1828 (792)

1876 (1120)

1897 (1074)

Min, Max

836, 6958

873, 3436

572, 6958

416, 6958

ADPKD risk classification

Class 1A

0

0

0

1 (1%)

Class 1B

2 (10%)

1 (9%)

10 (12%)

8 (9%)

Class 1C

5 (25%)

3 (27%)

25 (31%)

32 (36%)

Class 1D

8 (40%)

4 (36%)

31 (38%)

31 (35%)

Class 1E

5 (25%)

3 (27%)

16 (20%)

16 (18%)

  1. ADPKD autosomal dominant polycystic kidney disease, eGFR estimated glomerular filtration rate, Max maximum, Min minimum, SD standard deviation, TKV total kidney volume